ADVFN Logo
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

PHIO Phio Pharmaceuticals Corporation

0.6898
-0.1401 (-16.88%)
Apr 23 2024 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 653,303
Bid Price 0.671
Ask Price 0.72
News -
Day High 0.83

Low
0.50

52 Week Range

High
6.85

Day Low 0.6551
Company Name Stock Ticker Symbol Market Type
Phio Pharmaceuticals Corporation PHIO NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.1401 -16.88% 0.6898 20:00:00
Open Price Low Price High Price Close Price Prev Close
0.7189 0.6551 0.83 0.70 0.8299
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
1,428 653,303 $ 0.7361592 $ 480,935 - 0.50 - 6.85
Last Trade Time Type Quantity Stock Price Currency
19:51:33 formt 1,100 $ 0.6898 USD

Phio Pharmaceuticals Corporation Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
1.71M 2.44M - 0 -10.83M -4.43 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Phio Pharmaceuticals News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No PHIO Message Board. Create One! See More Posts on PHIO Message Board See More Message Board Posts

Historical PHIO Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.6491.050.6048490.82614171,494,2280.04086.29%
1 Month0.761.050.6048490.8102577444,121-0.0702-9.24%
3 Months0.581.150.54590.8444616454,5580.109818.93%
6 Months1.422.090.501.17509,820-0.7302-51.42%
1 Year3.736.850.502.38625,248-3.04-81.51%
3 Years27.4834.200.5015.67715,830-26.79-97.49%
5 Years5.94130.200.5019.06728,592-5.25-88.39%

Phio Pharmaceuticals Description

Phio Pharmaceuticals Corp is a US-based biotechnology company. It is principally engaged in developing immuno-oncology therapeutics based on its proprietary self-delivering RNAi platform and Samcyprone, a topical immunomodulator, which addresses significant unmet medical needs. The company's pipeline products include PH-762, PH-804, PH-790, and others.

Your Recent History

Delayed Upgrade Clock